Shed received a box of semaglutide earlier in the month with a much lower dose
CVOT trial will help determine if tirzepatide can demonstrate superior cardiovascular safety and potential additional cardiovascular benefits compared to the currently approved GLP-1RA dulaglutide
Daniel Long, DPhil, Senior Vice President of Drug Discovery Number Of Employees: ~130 Stage: Publicly traded Financial Snapshot: The companys market cap as of July 2026 was $1.49 billion
Lean mass loss with GLP-1 medicines is generally proportional to total weight lost, about 25 to 30 percent, similar to other weight-loss interventions, and physical function and quality of life improve
TrimRx offers personalized assessments to identify the best treatment for you
Detailed evaluations to see if GLP-1 therapy is right for the patient Guidance with insurance processes and discount programs Combining GLP-1 treatments with meal planning and fitness routines Regular check-ins to improve results and reduce any negative effects Reliable education helps patients choose health options with confidence